ImmuVen's Angel Round

ImmuVen raised a round of funding on September 17, 2010. Investors include Urbana-Champaign Angel Network.

ImmuVen develops drugs that can be used to treat infectious diseases and cancer. The company features life science technology, T cell receptors, a unique class of immune-targeting therapeutic and diag…

Articles about ImmuVen's Angel Round: